ACDRS 2025 Course

The Course emphasizes integrated product development that is science-based, efficient, economical, high quality, and rapid, leading to better and safer medical products for patients.

See how this rigorous, in-depth, comprehensive, and systematic immersion into modern medical product development, regulation, and market introduction can benefit your career by viewing testimonials from former ACDRS Course participants.

Dates and session themes

Jan 29, 2025

First day of instruction

Jan 29-31, 2025

Session 1

The Medical Product Development Enterprise: Past, Present, and Future Perspectives

Mar 5-7, 2025

Session 2

Learning Trials: From Discovery to First in Humans

Apr 2-4, 2025

Session 3

Learning and Confirming Trials: Finding and Confirming the Right Dose

May 14-16, 2025

Session 4

Statistics: Design, Analysis, and Interpretation of Clinical Trials

Sep 10-12, 2025

Session 5

Global Clinical Trials Authorization and Marketing Authorization Processes

Oct 22-24, 2025

Session 6

Integrated Product Development, Portfolio Management, Project Management, and Preparing for Transition to the Market

Oct 24, 2025

Last day of instruction

 

Examination

December 20, 2024

Cancellation deadline

This is a hybrid course with the option to attend in-person (in DC) or virtually (via Zoom) for three days of eight hours each day.

See the Course for topics and learning outcomes

Venue

University of California, Washington Center (UCDC), 1608 Rhode Island Ave NW, Washington, DC

Eligibility

You must:

  • have a higher university degree, such as MD, PharmD, PhD, Master’s, or JD (Applicants without terminal degrees but with extensive product development will be considered)

  • have a primary interest in medical product discovery, development, regulation, or related activity

  • have at least one year of work experience in medical product development

  • be qualified via standards and nominations by submitting a one-page curriculum vitae to [email protected] prior to or immediately following registration

Register

Registration fee: $15,000.00

A discounted fee for a limited number of participants from academia and government is available, please contact [email protected].

Enrollment is limited. You are encouraged to register well in advance. In case of cancellation before December 20, 2024 the fee (less $500.00 for administrative expenses) will be returned. There will be no substitute registrants or refund on cancellations made after this date.

For additional details, see FAQ.

"Participating in the American Course on Drug Development and Regulatory Sciences was a truly enriching experience. The course's structured approach provided deep insights into drug development and the regulatory process. The engaging lectures, real-world case studies, and practical exercises made the learning experience both informative and hands-on. The opportunity to network with experts and peers was invaluable. Overall, this course significantly enhanced my understanding of certain aspects and has undoubtedly benefited my career. I highly recommend it to anyone looking to deepen their knowledge of the biopharmaceutical industry, drug development, and regulatory sciences."
Joe Rappon, VP and Head of Pharma, Alcon